Market Access/ News/ News CHMP backs Sanofi’s Xenpozyme as first drug for ASMD Phil Taylor alopecia, EigerBio, Eli Lilly, Genzyme, Olumiant, progeria, rare disease, Sanofi, Xenpozyme, Zokinvy 0 Comment Sanofi’s Genzyme unit has moved a step closer to securing EU approval for Xenpozyme – its enzyme replacement Share X CHMP backs Sanofi’s Xenpozyme as first drug for ASMD https://pharmaphorum.com/news/chmp-backs-sanofis-xenpozyme-as-first-drug-for-asmd/